Author

Zhengfeng Yin

Observed names: Z Yin, Z. Yin, Zheng-Feng Yin, Zheng-feng YIN, Zheng-feng Yin, Zhenghao Yin, Zheng‐Feng Yin

Observed institutions: Fujian Medical University, Karolinska University Hospital, Guiyang Medical University, Second Military Medical University, Renji Hospital, Karolinska Institutet, Affiliated Hospital of Guizhou Medical University, Eastern Hepatobiliary Surgery Hospital, Universidade Federal de Goiás

ORCID: 0009-0006-4625-1202

Observed ORCID: 0009-0006-4625-1202

OpenAlex ID: A5100650792

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines

2011 · Lu Cao, Yanming Zhou, et al. · BMC Gastroenterology · 289

PDF

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma

2010 · Yanming Zhou, Yanfang Zhao, et al. · BMC Gastroenterology · 199

PDF

Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China

2008 · Yan-Ming Zhou, Zheng-Feng Yin, et al. · World Journal of Gastroenterology · 171

PDF

Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy

2011 · Wen Xu, Lu Cao, et al. · Clinical Cancer Research · 163

Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review

2010 · Yanming Zhou, Chengjun Sui, et al. · World Journal of Surgical Oncology · 114

PDF

CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis

2015 · You-Chuan Xiao, Zhi-Bin Yang, et al. · Cancer Letters · 106

Clinicopathological Significance of ZEB1 Protein in Patients with Hepatocellular Carcinoma

2011 · Yan-Ming Zhou, Lu Cao, et al. · Annals of Surgical Oncology · 92

Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models

2019 · Youngsoo Kim, Minji Jo, et al. · Molecular Therapy · 81

PDF

Circulating Tumor Cells in Hepatocellular Carcinoma: Detection Techniques, Clinical Implications, and Future Perspectives

2012 · Yu Zhang, Jun Li, et al. · Seminars in Oncology · 79

The biological and clinical importance of epithelial–mesenchymal transition in circulating tumor cells

2014 · Huiying Liu, Xiaofeng Zhang, et al. · Journal of Cancer Research and Clinical Oncology · 75

Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.

2010 · Yan-Ming Zhou, Jia-Mei Yang, et al. · PubMed · 73

Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay

2016 · Yu Zhang, Xiaofeng Zhang, et al. · Cancer Biology & Therapy · 68

PDF

Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin

2014 · Jun Li, Lei Chen, et al. · PLoS ONE · 66

PDF

Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells

2017 · Bin Sun, Congli Hu, et al. · Oncotarget · 59

PDF

pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma

2015 · Jun Li, Lehua Shi, et al. · Oncotarget · 55

PDF

MCM 7 expression predicts post‐operative prognosis for hepatocellular carcinoma

2012 · Yan‐Ming Zhou, Xiao‐Feng Zhang, et al. · Liver International · 50

Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study

2011 · Zhen-Yu Liu, Yan-Ming Zhou, et al. · Hepatobiliary & pancreatic diseases international · 50

Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein

2008 · Yan-Ming Zhou, Jia-Mei Yang, et al. · World Journal of Gastroenterology · 43

PDF

hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers

2011 · Weidan Ji, Jiahe Yang, et al. · PLoS ONE · 36

PDF

Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma

2013 · Bin Sun, Xiaofeng Zhang, et al. · PLoS ONE · 28

PDF

Icaritin ameliorates carbon tetrachloride-induced acute liver injury mainly because of the antioxidative function through estrogen-like effects

2014 · Peng Liu, Xiang Jin, et al. · In Vitro Cellular & Developmental Biology - Animal · 27

Lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein as a Marker of Prognosis and a Monitor of Recurrence of Hepatocellular Carcinoma After Curative Liver Resection

2011 · Xiao-Feng Zhang, Eric C. H. Lai, et al. · Annals of Surgical Oncology · 24

Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma

2012 · Yan-Ming Zhou, Lu Cao, et al. · Hepatobiliary & pancreatic diseases international · 23

Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytesin vivoandin vitro

2019 · Wen-Chao Wang, Zong-Qin Zhang, et al. · Cancer Biology & Therapy · 19

PDF

Advances and Challenges in RAS Signaling Targeted Therapy in Leukemia

2024 · Yu Chen, Zhenghao Yin, et al. · Molecular Cancer Therapeutics · 15

PDF

Works count: 58

Citation count: 2,067

H-index: 23

I10-index: 29